Aclarion, Inc. (ACON): Nasdaq/NYSE listing notice — Aclarion receives Nasdaq notice for non-compliance with $1.00 minimum bid price requirement

Aclarion, Inc.

Nasdaq notice dated Aug 4, 2023, due to closing bid price below $1.00 for 30 consecutive business days through Aug 3, 2023.
Company has 180 calendar days to regain compliance by closing at or above $1.00 for ten consecutive business days.
If not cured, may be eligible for additional 180 days if meeting market value of publicly held shares and other listing requirements.
Company intends to monitor bid price and consider options including a reverse stock split if necessary.
Notice does not affect business operations or SEC reporting obligations.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Aclarion, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

August 4, 2023, Aclarion, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per

View on SEC.gov

Browse all listing & compliance notices →

Aclarion, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-005523

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.